V. Drory

R. Conwit, J. Licht, P. Andersen, 2012, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

ALSUntangled No. 36: Accilion

R. Conwit, J. Licht, P. Andersen, 2017, Amyotrophic lateral sclerosis & frontotemporal degeneration.

R‐R interval variation in Parkinson's disease and multiple system atrophy

Jeffrey M. Hausdorff, Nir Giladi, V. Drory, 2004, Acta neurologica Scandinavica.

Common genetic basis of ALS patients and soccer players may contribute to disease risk

D. Nemet, Y. Meckel, A. Eliakim, 2022, Neurological Sciences.

Mutations in the CHCHD10 gene are a common cause of familial amyotrophic lateral sclerosis.

Janel O. Johnson, M. Nalls, A. Chiò, 2014, Brain : a journal of neurology.

No effect of creatine on respiratory distress in amyotrophic lateral sclerosis

V. Drory, Ditza Gross, 2002, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre‐randomization phase of the Polyneuropathy And Treatment with Hizentra study

D. Yarnitsky, M. Valis, H. Hartung, 2019, Journal of the peripheral nervous system : JPNS.

Assessment of experimental autoimmune neuritis in the rat by electrophysiology of the tail nerve

V. Drory, J. Chapman, M. Kafri, 2002, Muscle & nerve.

Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis

Sonja W. Scholz, Hannah A. Pliner, Janel O. Johnson, 2021, JAMA neurology.

Muscle thickness measured by ultrasound is reduced in neuromuscular disorders and correlates with clinical and electrophysiological findings

V. Drory, L. E. Lovblom, V. Bril, 2019, Muscle & nerve.

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

G. L. Masson, D. Yarnitsky, S. Muley, 2018, The Lancet Neurology.

The Effect of SMN Gene Dosage on ALS Risk and Disease Severity

M. Eberle, A. Al-Chalabi, P. Andersen, 2021, Annals of neurology.

Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.

Timothy A. Miller, Sonja W. Scholz, Jennifer E. Phillips-Cremins, 2020, Neuron.

Inhibition of Ras attenuates the course of experimental autoimmune neuritis

V. Drory, J. Chapman, M. Kafri, 2005, Journal of Neuroimmunology.

Novel mutation in VCP gene causes atypical amyotrophic lateral sclerosis

D. Goldstein, Robert H. Brown, A. Fox, 2012, Neurology.

High frequency of C9orf72 hexanucleotide repeat expansion in amyotrophic lateral sclerosis patients from two founder populations sharing the same risk haplotype

B. Traynor, V. Drory, A. Orr-Urtreger, 2017, Neurobiology of Aging.

Combination of ciprofloxacin/celecoxib as a novel therapeutic strategy for ALS

S. Paganoni, V. Drory, J. Shefner, 2022, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Transglutaminase 6 Antibodies in the Serum of Patients With Amyotrophic Lateral Sclerosis.

V. Drory, A. Gadoth, B. Nefussy, 2015, JAMA neurology.

Dynamic MRI testing of the cervical spine has prognostic significance in patients with progressive upper-limb distal weakness and atrophy

S. Blumen, V. Drory, J. Gomori, 2014, Journal of the Neurological Sciences.

Earlier onset and shorter survival of amyotrophic lateral sclerosis in Jewish patients of North African origin A clue to modifying genetic factors?

V. Drory, I. Artmonov, 2007, Journal of the Neurological Sciences.

Hexosaminidase A deficiency is an uncommon cause of a syndrome mimicking amyotrophic lateral sclerosis

V. Drory, A. Korczyn, L. Peleg, 2003, Muscle & nerve.

Outcome of percutaneous endoscopic gastrostomy insertion in patients with amyotrophic lateral sclerosis in relation to respiratory dysfunction

V. Drory, M. Sarfaty, N. Vaisman, 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Value of repeat electromyographic studies in patients with stable lumbar radiculopathies

V. Drory, G. B. Groozman, 2007 .

Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial

G. L. Masson, C. Ervin, H. Hartung, 2018, The Lancet Neurology.

Genome-wide Analyses Identify KIF5A as a Novel ALS Gene in and for Therapeutic

Timothy A. Miller, Denis C. Bauer, Shankaracharya, 2018 .

Aggressive familial ALS with unusual brain MRI and a SOD1 gene mutation

P. Andersen, S. Blumen, R. Carasso, 2010, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

Mutations in the tail domain of the neurofilament heavy chain gene increase the risk of amyotrophic lateral sclerosis

A. Al-Chalabi, J. Glass, J. Landers, 2022, medRxiv.

Large-scale analyses of CAV1 and CAV2 suggest their expression is higher in post-mortem ALS brain tissue and affects survival

Ashley R. Jones, G. Breen, A. Al-Chalabi, 2022, Frontiers in Cellular Neuroscience.

Immunohistochemical analysis of sympathetic involvement in the SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis

V. Drory, A. Korczyn, D. Offen, 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Smoking and amyotrophic lateral sclerosis

V. Drory, A. Korczyn, A. Korczyn, 2009, Annals of neurology.

ALSUntangled: Introducing The Table of Evidence

R. Conwit, J. Licht, P. Andersen, 2015, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Association of APOE epsilon4 allele with survival in amyotrophic lateral sclerosis.

V. Drory, J. Chapman, A. Korczyn, 2001, Journal of the neurological sciences.

Neurosarcoidosis presenting as Guillain-Barré-like syndrome. A case report and review of the literature.

V. Drory, F. Fahoum, J. Issakov, 2009, Journal of clinical neuromuscular disease.

Effect of ethnic origin and gender on the clinical manifestations of myasthenia gravis among the Jewish population in Israel

V. Drory, A. Kesler, A. Karni, 2017, Journal of Neuroimmunology.

A test for the evaluation of the lateral cutaneous branch of the iliohypogastric nerve using somatosensory evoked potentials

V. Drory, M. Rabie, 2005, Journal of the Neurological Sciences.

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

V. Drory, A. Korczyn, D. Offen, 2013 .

Hypersensitivity vasculitis and systemic lupus erythematosus induced by anticonvulsants.

V. Drory, A. Korczyn, A. Korczyn, 1993, Clinical neuropharmacology.

The value of muscle exercise in patients with amyotrophic lateral sclerosis

A. Mosek, V. Drory, A. Korczyn, 2001, Journal of the Neurological Sciences.

Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

Ewout J. N. Groen, Annelot M. Dekker, Ross P. Byrne, 2021, Nature Genetics.

Genome-wide study of DNA methylation in Amyotrophic Lateral Sclerosis identifies differentially methylated loci and implicates metabolic, inflammatory and cholesterol pathways

Annelot M. Dekker, Ahmad Al Khleifat, N. Wray, 2021, medRxiv.

Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS

Annelot M. Dekker, N. Wray, A. McRae, 2022, Science Translational Medicine.

Evoked potential studies in the antiphospholipid syndrome: differential diagnosis from multiple sclerosis

V. Drory, J. Chapman, Y. Segev, 2005, Annals of the rheumatic diseases.

An integrated multi-omic analysis of iPSC-derived motor neurons from C9ORF72 ALS patients

Timothy A. Miller, Jennifer E. Phillips-Cremins, Andrea D Matlock, 2020, bioRxiv.

Mechanism, prevalence, and more severe neuropathy phenotype of the Charcot-Marie-Tooth type 1A triplication.

J. Lupski, V. Drory, J. Higgins, 2014, American journal of human genetics.

Toward a Personalized Approach in Amyotrophic Lateral Sclerosis: New Developments in Diagnosis, Genetics, Pathogenesis and Therapies

V. Drory, B. Nefussy, 2013 .

Mutations in the Profilin 1 Gene Cause Familial Amyotrophic Lateral Sclerosis

S. C. Chafe, D. Goldstein, Robert H. Brown, 2012, Nature.

Moving toward a predictive and personalized clinical approach in amyotrophic lateral sclerosis: novel developments and future directions in diagnosis, genetics, pathogenesis and therapies

V. Drory, B. Nefussy, 2010, EPMA Journal.

Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

Ewout J. N. Groen, Annelot M. Dekker, Ross P. Byrne, 2021, Nature Genetics.

Thrombin receptor PAR-1 on myelin at the node of Ranvier: a new anatomy and physiology of conduction block.

D. Gurwitz, V. Drory, J. Chapman, 2008, Brain : a journal of neurology.

The sympathetic skin response in reflex sympathetic dystrophy

V. Drory, A. Korczyn, 1995, Journal of the Neurological Sciences.

Occurrence of fatigue over 20 years after recovery from Guillain–Barré syndrome

A. Catz, V. Drory, A. Korczyn, 2012, Journal of the Neurological Sciences.

Longer-term follow-up of nusinersen efficacy and safety in adult patients with spinal muscular atrophy types 2 and 3

V. Drory, A. Abraham, Beatrice Abramovich, 2022, Neuromuscular Disorders.

ALS Untangled No. 17: “When ALS Is Lyme”

R. Conwit, J. Licht, P. Andersen, 2012, Amyotrophic Lateral Sclerosis.

Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study

Janel O. Johnson, D. Hernandez, M. Nalls, 2012, The Lancet Neurology.

Oculopharyngeal muscular dystrophy among Bulgarian Jews: a new cluster?

S. Blumen, B. Brais, V. Drory, 2013, The Israel Medical Association journal : IMAJ.

Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis

Lorne Zinman, Adriano Chiò, Richard W. Orrell, 2014, Nature Neuroscience.

Posterior reversible encephalopathy syndrome resulting from Guillain-Barré-like syndrome secondary to West Nile virus infection.

V. Drory, A. Abraham, Sari Ziv, 2011, Journal of clinical neuromuscular disease.

Association of APOE ε4 allele with survival in amyotrophic lateral sclerosis

V. Drory, J. Chapman, A. Korczyn, 2001, Journal of the Neurological Sciences.

Recombinant human granulocyte-colony stimulating factor administration for treating amyotrophic lateral sclerosis: A pilot study

V. Drory, A. Nagler, V. Deutsch, 2010, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

Neurotoxicity of isolated limb perfusion with tumor necrosis factor

V. Drory, D. Lev, J. Klausner, 1995, Journal of the Neurological Sciences.

Postradiation lower motor neuron syndrome: case series and literature review

V. Drory, A. Abraham, 2013, Journal of Neurology.

Sympathetic skin response

Amos D. Korczyn, Vivian E. Drory, V. Drory, 1993, Neurology.

Carbamazepine induced systemic lupus erythematosus.

V. Drory, A. Korczyn, I. Yust, 1989, British medical journal.

Carbamazepine-induced systemic lupus erythematosus.

V. Drory, A. Korczyn, I. Yust, 1989, Clinical neuropharmacology.

sclerosis syndrome : differential diagnosis from multiple Evoked potential studies in the antiphospholipid

V. Drory, J. Chapman, Y. Segev, 2005 .

OPTN 691_692insAG is a founder mutation causing recessive ALS and increased risk in heterozygotes

B. Traynor, V. Drory, A. Renton, 2016, Neurology.

Rare homozygosity in amyotrophic lateral sclerosis suggests the contribution of recessive variants to disease genetics

V. Drory, A. Orr-Urtreger, M. Kedmi, 2019, Journal of the Neurological Sciences.

ALSUntangled No. 16: Cannabis

R. Conwit, J. Licht, P. Andersen, 2012, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

Low‐grade systemic inflammation in patients with amyotrophic lateral sclerosis

V. Drory, S. Berliner, O. Rogowski, 2009, Acta neurologica Scandinavica.

Fatigue in motor neuron diseases

V. Drory, 2016, Clinical Neurophysiology.

Fatigue in motor neuron diseases

V. Drory, A. Abraham, 2012, Neuromuscular Disorders.

The Sensitivity and Specificity of Split-Hand Index Using Muscle Sonography

V. Drory, V. Bril, A. Abraham, 2022, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Split-hand phenomenon in motor neuron diseases: Sonographic assesment of muscle thickness

V. Drory, V. Bril, A. Abraham, 2020, Clinical Neurophysiology.

Electrophysiologic evaluation of upper motor neuron involvement in amyotrophic lateral sclerosis

V. Drory, G. B. Groozman, Ivan Kovach, 2001, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

Abstracts of the 16th Annual Meeting of The Israel Society for Neuroscience Eilat, Israel, November 25–27, 2007

Yonina C. Eldar, Karl J. Friston, Leslie G. Ungerleider, 2008, Neural plasticity.

Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies

G. L. Masson, D. Yarnitsky, M. Valis, 2019, Journal of the peripheral nervous system : JPNS.

Effect of neck flexion on somatosensory and motor evoked potentials in Hirayama disease

S. Blumen, V. Drory, M. Gotkine, 2013, Journal of the Neurological Sciences.

The Use of Intravenous Immunoglobulin as Maintenance Therapy in Myasthenia Gravis

V. Drory, J. Chapman, A. Korczyn, 2001, Clinical neuropharmacology.

Gender-based effect of statins on functional decline in amyotrophic lateral sclerosis

V. Drory, M. Cudkowicz, B. Nefussy, 2011, Journal of the Neurological Sciences.

Preface: promoting research in PLS: current knowledge and future challenges

R. Conwit, S. Paganoni, S. Ajroud‐Driss, 2020, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Wet, volatile, and dry biomarkers of exercise-induced muscle fatigue

J. Finsterer, V. Drory, Josef Finsterer, 2016, BMC Musculoskeletal Disorders.

ALSUntangled No. 26: Lunasin

R. Conwit, J. Licht, P. Andersen, 2014, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Clinical Characteristics of Elderly Patients with Amyotrophic Lateral Sclerosis (P2.013)

V. Drory, I. Artman, Tami Nussbaum, 2015 .

Early post-marketing experience with edaravone in an unselected group of patients with ALS

V. Drory, A. Karni, A. Abraham, 2019, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Do patients with amyotrophic lateral sclerosis (ALS) have increased energy needs?

V. Drory, N. Vaisman, D. Comaneshter, 2009, Journal of the Neurological Sciences.

Anal sphincter EMG does not distinguish between multiple system atrophy and Parkinson's disease

Nir Giladi, V. Drory, A. Korczyn, 2000 .

Autonomic impairment in a transgenic mouse model of amyotrophic lateral sclerosis

V. Drory, A. Korczyn, B. Kandinov, 2011, Autonomic Neuroscience.

N30 somatosensory evoked potentials in patients with unilateral Parkinson's disease

V. Drory, R. Inzelberg, G. B. Groozman, 1998, Acta neurologica Scandinavica.

The NEALS primary lateral sclerosis registry

N. Staff, S. Paganoni, V. Drory, 2020, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: A double- blind, randomized, multicentre, placebo-controlled trial

P. Leigh, V. Meininger, W. Robberecht, 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

Blood pressure measurements in a transgenic SOD1-G93A mouse model of amyotrophic lateral sclerosis

V. Drory, A. Korczyn, K. Tordjman, 2012, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

Cross-cultural variation in mental health at end of life in patients with ALS

S. Albert, V. Drory, G. Borasio, 2007, Neurology.

Characterization of patients with ocular myasthenia gravis — A case series

V. Drory, A. Kesler, A. Karni, 2016, eNeurologicalSci.

Predicting functional impairment trajectories in amyotrophic lateral sclerosis: a probabilistic, multifactorial model of disease progression

R. Rinaldi, B. Di Camillo, M. Vinceti, 2022, Journal of Neurology.

Unsupervised machine-learning identifies clinically distinct subtypes of ALS that reflect different genetic architectures and biological mechanisms

Ahmad Al Khleifat, A. Al-Chalabi, P. Andersen, 2023, medRxiv.

Abstracts of the 16th Annual Meeting of The Israel Society for Neuroscience Eilat, Israel, November 25–27, 2007

Yonina C. Eldar, Karl J. Friston, Leslie G. Ungerleider, 2008, Neural plasticity.

Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias

Ryan L. Collins, Sonja W. Scholz, Toshiko Tanaka, 2023, Cell genomics.

Early perceptual loss in depression

Yonina C. Eldar, Karl J. Friston, Charles R. Seger, 2007 .

ALSUntangled No. 34: GM604.

R. Conwit, J. Licht, P. Andersen, 2016, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration.

Listening to music during electromyography does not influence the examinee's anxiety and pain levels

V. Drory, A. Abraham, 2014, Muscle & nerve.

A novel mutation in TARDBP segregates with amyotrophic lateral sclerosis in a large family with early onset and fast progression

V. Drory, A. Orr-Urtreger, M. Kedmi, 2020, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Mutational analysis of glycyl-tRNA synthetase (GARS) gene in Hirayama disease

S. Blumen, J. Bouchard, V. Drory, 2010, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

Fasciculation frequency at the biceps brachii and brachialis muscles is associated with amyotrophic lateral sclerosis disease burden and activity

V. Drory, V. Bril, A. Abraham, 2020, Muscle & nerve.

ALSUntangled No. 29: MitoQ

R. Conwit, J. Licht, P. Andersen, 2015, Amyotrophic lateral sclerosis & frontotemporal degeneration.

ALSUntangled No. 27: Precision Stem Cell

V. Drory, J. Shefner, K. Sharma, 2015, Amyotrophic lateral sclerosis & frontotemporal degeneration.

A potential tool for the diagnosis of ALS based on diffusion tensor imaging

Ricardo Tarrasch, Dafna Ben Bashat, Moran Artzi, 2011, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study

Janel O. Johnson, D. Hernandez, M. Nalls, 2012, The Lancet Neurology.

Genetic and phenotype analyses of primary lateral sclerosis datasets from international cohorts

A. Al-Chalabi, C. Shaw, P. Andersen, 2023, medRxiv.

Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study

Janel O. Johnson, D. Hernandez, G. Schellenberg, 2012, The Lancet Neurology.

Correlation between oculometric measures and clinical assessment in ALS patients participating in a phase IIb clinical drug trial

V. Drory, Eitan Raveh, Nurit Birman, 2023, Amyotrophic lateral sclerosis & frontotemporal degeneration.

ALSUntangled No. 36: Accilion

R. Conwit, J. Licht, P. Andersen, 2017, Amyotrophic lateral sclerosis & frontotemporal degeneration.

The Project MinE databrowser: bringing large-scale whole-genome sequencing in ALS to researchers and the public

Naomi R. Wray, Mamede de Carvalho, Blaz Koritnik, 2018, bioRxiv.